NK Cell Therapies Pipeline Report 2024: Insights on 80+ Companies and 100+ Pipeline Drugs, Including ALECSAT (CytoVac), NKTR-214/Bempegaldesleukin (Nektar Therapeutics), and Monalizumab (Innate Pharma)
April 26, 2024 04:12 ET
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "NK Cell Therapies - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
CAR-T Funding Report 2024: Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions
March 18, 2024 04:52 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2024" report has been added to ...
MesoPher as a Maintenance Treatment after Chemotherapy, 2023 Research Report: Drug Insights and Market Forecasts, 2019-2032 - Focus on 7 Major Markets
November 23, 2023 11:13 ET
|
Research and Markets
Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "MesoPher Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Global Natural Killer NK Cell Therapy Market Clinical Trials Companies Insight 2023
March 20, 2023 02:22 ET
|
KuicK Research
Delhi, March 20, 2023 (GLOBE NEWSWIRE) -- Global Natural Killer (NK) Cell Therapeutics Market Trends, Companies & Clinical Trials Insight 2023 Report Highlights: Global Natural Killer (NK)...
Cellular Immunotherapy (CAR T Cell Therapy, Dendritic Cell Therapy) Market Trends/Analysis Report 2022
January 06, 2023 06:03 ET
|
Research and Markets
Dublin, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Cellular Immunotherapy Market Size, Share & Trends Analysis Report by Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy), by...
Natural Killer (NK) Cell Therapeutics Market Research Report 2022
August 09, 2022 06:08 ET
|
Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) Cell Therapeutics Market - A Global and Regional Analysis: Focus on NK Cell Therapy Type, Indication, Country, Pipeline Analysis,...
aTyr Pharma Announces New tRNA Synthetase Discovery Programs
February 11, 2021 08:00 ET
|
aTyr Pharma, Inc.
Advancement of selected AARS and DARS fragments primarily targeting cancer Programs will accelerate discoveries initially focusing on natural killer (NK) cell biology SAN DIEGO , Feb. 11, 2021 ...
Hemispherx Biopharma Reports Low NK Cell Activity in Chronic Fatigue Syndrome (CFS) and Relationship to Disease Symptoms
September 15, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 15, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today the publication in the current issue of the peer reviewed Journal of Clinical and Cellular...